It is a pharma private limited company based in East Delhi, Delhi, India, established in 2003.
2003 | East Delhi, Delhi, India | ActiveSaisun Pharma Private Limited, a active private limited company, was established on 27 June 2003 in East Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231DL2003PTC121103. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 3 professional, Its leadership includes Nyapati Venkata Satya Giridhar (Director), Sanal Kumar Kuttikkat (Director). Past directors included Raghuram Nyaypati. It holds ₹11.16 Cr open charges and ₹2.22 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Property No. 454, F.I.E. First Floor Patparganj Industrial Area,, East Delhi, Delhi, 110092.
U24231DL2003PTC121103
121103
27 June 2003
₹1.00 M
₹1.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Saisun Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nyapati Venkata Satya Giridhar | Director | 27 Jun 2003 | Current |
| Sanal Kumar Kuttikkat | Director | 01 Apr 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Mar 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Saisun Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.08% increase. The company also saw a substantial improvement in profitability, with a 34.47% increase in profit. The company's net worth Soared by an impressive increase of 16.89%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Saisun Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹111,600,000.00
₹22,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Sep 2024 | Others | ₹11.00 Cr | Open |
| 18 Feb 2022 | Others | ₹1.60 M | Open |
| 30 Mar 2024 | Idbi Bank Limited | ₹6.50 M | Satisfied |
| 04 May 2013 | Idbi Bank Limited | ₹1.57 Cr | Satisfied |
Explore comprehensive loan charge details -
Saisun Pharma has a workforce of 3 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Saisun Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saisun Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 110.00 M registered on 13 Sep 2024 with Charge ID 100979783 was modified on 19 Aug 2025. was documented.
The activity A charge registered on 30 Mar 2024 via Charge ID 100904635 with Idbi Bank Limited was fully satisfied on 02 Dec 2024. was completed.
A charge registered on 04 May 2013 via Charge ID 10428934 with Idbi Bank Limited was fully satisfied on 02 Dec 2024. was recorded as a recent event.
The activity Saisun Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge with Others amounted to Rs. 110.00 M with Charge ID 100979783 was registered on 13 Sep 2024. was recorded as a recent event.
Saisun Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The CIN of Saisun Pharma Private Limited is U24231DL2003PTC121103.
Saisun Pharma Private Limited is headquartered at Property No. 454, F.I.E. First Floor Patparganj Industrial Area,, East Delhi, Delhi, 110092.
Saisun Pharma Private Limited was incorporated on 27 June 2003.
The current directors of Saisun Pharma Private Limited are
The primary industry of Saisun Pharma Private Limited is Trade.
Saisun Pharma Private Limited is unlisted.
The authorized capital of Saisun Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Saisun Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX